2022
DOI: 10.1021/acschembio.2c00306
|View full text |Cite
|
Sign up to set email alerts
|

Simple, Rapid Chemical Labeling and Screening of Antibodies with Luminescent Peptides

Abstract: Sensitive and selective detection assays are essential for the accurate measurement of analytes in both clinical and research laboratories. Immunoassays that rely on nonoverlapping antibodies directed against the same target analyte (e.g., sandwich enzyme-linked immunosorbent assays (ELISAs)) are commonly used molecular detection technologies. Use of split enzyme reporters has simplified the workflow for these traditionally complex assays. However, identifying functional antibody pairs for a given target analy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
5
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
3
1

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(5 citation statements)
references
References 29 publications
0
5
0
Order By: Relevance
“…NanoBiT-based technology has recently been developed with various synthetic scaffolds and applied for different tests, including but not limited to SARS-CoV-2 (COVID-19), , Clostridium difficile infections, , and botulinum neurotoxins . While efforts have been reported in combining NanoBiT with full-length antibodies, the most common and versatile protein-based binder so far, such antibody engineering usually relies on chemical conjugation of antibody with LgBiT or SmBiT, which necessitates not only the costly production of antibodies, but also extensive purifications due to the heterogeneity of products. While primary efforts suggested Fab binder tagged with a short peptide (peptide β9 from NanoLuc) is compatible with the NanoBiT system, we reasoned that directly fusing NanoBiT with Fab could address the challenges associated with antibody conjugation, thereby fully leveraging Fab’s versatility.…”
Section: Resultsmentioning
confidence: 99%
“…NanoBiT-based technology has recently been developed with various synthetic scaffolds and applied for different tests, including but not limited to SARS-CoV-2 (COVID-19), , Clostridium difficile infections, , and botulinum neurotoxins . While efforts have been reported in combining NanoBiT with full-length antibodies, the most common and versatile protein-based binder so far, such antibody engineering usually relies on chemical conjugation of antibody with LgBiT or SmBiT, which necessitates not only the costly production of antibodies, but also extensive purifications due to the heterogeneity of products. While primary efforts suggested Fab binder tagged with a short peptide (peptide β9 from NanoLuc) is compatible with the NanoBiT system, we reasoned that directly fusing NanoBiT with Fab could address the challenges associated with antibody conjugation, thereby fully leveraging Fab’s versatility.…”
Section: Resultsmentioning
confidence: 99%
“…HiBiT, a high-affinity strand 10 peptide, has been identified as the preferred strand 10 peptide (β10) based on luminescent signal output in the ternary system and was carried through for these experiments. We further evolved the strand 9 (β9) derived peptide as well as LgTrip to overcome poor aqueous solubility and improve protein stability ( Hall et al, 2021 ; Kincaid et al, 2022 ; Supplementary Figure 1 ). To create the chemical conjugation reporter tags, we relied on HaloTag-mediated chemical labeling of a pair of complementary antibodies that recognized non-overlapping epitopes of the target analyte ( Nath et al, 2017 ).…”
Section: Resultsmentioning
confidence: 99%
“…Using this model system, we showcased another accommodating assay feature of the ternary, split-Nluc platform, namely the ability to append β9 and β10 peptides as genetic fusions rather than the chemical labeling approach used in the antigen assay. This and a recently published study have focused on transitioning the ternary Nluc technology from HaloTag-based labeling approach to direct peptide labeling and genetic fusions to enable flexible labeling options for different targets and model systems( Kincaid et al, 2022 ). The direct labeling and genetic fusion methods use smaller peptide tags that are bioinert and can be easily appended anywhere on targets of interest.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…NanoLuc (Nluc) is an engineered bioluminescent protein developed by Promega in 2012 with numerous applications in molecular and cellular biology. Although other bioluminescent probes are available, including widely used Firefly Luciferase (Fluc) and Renilla Luciferase (Rluc), Nluc has several important advantages, such as a smaller size, greatly increased brightness, and significantly increased structural and enzymatic stability. ,,,,,,,, Nluc originated from a small subunit of the deep sea shrimp Oplophorus luciferase (OLuc). ,, This subunit, OLuc19, is bioluminescent, reacting in an ATP-independent reaction with coelenterazine ,,,, producing blue light, which is used by the shrimp as a self-defense mechanism against predators. Since OLuc19 was unstable and aggregated when expressed in Escherichia coli cells, various steps of amino acid mutations and substrate optimization were performed to stabilize this 19 kDa subunit.…”
Section: Introductionmentioning
confidence: 99%